Stock Track | Option Care Health Soars 5% on Price Target Hike and Strong Q4 Revenue Outlook

Stock Track

01/15

Option Care Health Inc (OPCH) shares soared 5.01% on Tuesday's intraday trading session, outperforming the broader market. The rally came as analysts raised their price targets and the company issued preliminary Q4 and full-year 2024 results showing robust revenue growth expectations.

Barrington Research raised its price target on OPCH to $33 from $32, maintaining an Outperform rating on the stock. The analysts cited the company's strong preliminary financial results as the catalyst for the raised outlook.

Option Care Health expects to report net revenues between $1.34 billion to $1.35 billion for Q4 2024, representing an impressive 19.2% to 20.1% year-over-year growth. For the full year 2024, the company projects net revenues to increase between $5.2 billion to $5.4 billion compared to 2023. These robust top-line growth estimates, driven by the company's strategic initiatives and favorable market conditions, have boosted investor confidence in the stock.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1185789110"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1185789110\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1185789110?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-15 04:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1185789110","market":"us","top_or_hot":-1,"title":"Stock Track | Option Care Health Soars 5% on Price Target Hike and Strong Q4 Revenue Outlook","media":"Stock Track","content":"<p>Option Care Health Inc (OPCH) shares soared 5.01% on Tuesday's intraday trading session, outperforming the broader market. The rally came as analysts raised their price targets and the company issued preliminary Q4 and full-year 2024 results showing robust revenue growth expectations.</p>\n\n<p>Barrington Research raised its price target on OPCH to $33 from $32, maintaining an Outperform rating on the stock. The analysts cited the company's strong preliminary financial results as the catalyst for the raised outlook.</p>\n\n<p>Option Care Health expects to report net revenues between $1.34 billion to $1.35 billion for Q4 2024, representing an impressive 19.2% to 20.1% year-over-year growth. For the full year 2024, the company projects net revenues to increase between $5.2 billion to $5.4 billion compared to 2023. These robust top-line growth estimates, driven by the company's strategic initiatives and favorable market conditions, have boosted investor confidence in the stock.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Option Care Health Soars 5% on Price Target Hike and Strong Q4 Revenue Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Option Care Health Soars 5% on Price Target Hike and Strong Q4 Revenue Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-01-15 04:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Option Care Health Inc (OPCH) shares soared 5.01% on Tuesday's intraday trading session, outperforming the broader market. The rally came as analysts raised their price targets and the company issued preliminary Q4 and full-year 2024 results showing robust revenue growth expectations.</p>\n\n<p>Barrington Research raised its price target on OPCH to $33 from $32, maintaining an Outperform rating on the stock. The analysts cited the company's strong preliminary financial results as the catalyst for the raised outlook.</p>\n\n<p>Option Care Health expects to report net revenues between $1.34 billion to $1.35 billion for Q4 2024, representing an impressive 19.2% to 20.1% year-over-year growth. For the full year 2024, the company projects net revenues to increase between $5.2 billion to $5.4 billion compared to 2023. These robust top-line growth estimates, driven by the company's strategic initiatives and favorable market conditions, have boosted investor confidence in the stock.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OPCH","symbol_name":"Option Care Health Inc","start_time":0,"source_url":"","article_id":"1185789110","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1185789110","pubTimestamp":1736886306,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Option Care Health Inc  shares soared 5.01% on Tuesday's intraday trading session, outperforming the broader market. The rally came as analysts raised their price targets and the company issued preliminary Q4 and full-year 2024 results showing robust revenue growth expectations.Barrington Research raised its price target on OPCH to $33 from $32, maintaining an Outperform rating on the stock. The analysts cited the company's strong preliminary financial results as the catalyst for the raised outl","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OPCH":"Option Care Health Inc"},"translate_title":"股票跟踪期权Care Health因价格目标上调和强劲的第四季度收入前景而飙升5%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OPCH":1},"content_text":"Option Care Health Inc (OPCH) shares soared 5.01% on Tuesday's intraday trading session, outperforming the broader market. The rally came as analysts raised their price targets and the company issued preliminary Q4 and full-year 2024 results showing robust revenue growth expectations.\nBarrington Research raised its price target on OPCH to $33 from $32, maintaining an Outperform rating on the stock. The analysts cited the company's strong preliminary financial results as the catalyst for the raised outlook.\nOption Care Health expects to report net revenues between $1.34 billion to $1.35 billion for Q4 2024, representing an impressive 19.2% to 20.1% year-over-year growth. For the full year 2024, the company projects net revenues to increase between $5.2 billion to $5.4 billion compared to 2023. These robust top-line growth estimates, driven by the company's strategic initiatives and favorable market conditions, have boosted investor confidence in the stock.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}